What Happened?
Dallas, TX-based Taysha Gene Therapies Appointed Frederick Porter as Chief Technical Officer
About the Company
Taysha Gene Therapies is on a mission to eradicate monogenic CNS disease. With a singular focus on developing curative medicines, we hope to rapidly translate our treatments from bench to bedside. We have combined our team`s proven experience in gene therapy drug development and commercialization with the world-class UT Southwestern Gene Therapy Program to quickly and efficiently build an extensive, AAV gene therapy pipeline focused on both rare and large-market indications. Together, we leverage our fully integrated platform—an engine for new cures—to dramatically improve patients` lives.
About the Person
Frederick Porter is Chief Technical Officer at Taysha Gene Therapies. Previously, Frederick held various senior IT leadership roles in the industry.
Info Source
News
Short Profile